Ingrid Lux

Ingrid Lux is a seasoned professional in quality operations and pharmaceutical management with extensive experience spanning over two decades. Currently serving as Director of Quality Disposition for Oncology and External Supply Small Molecule Europe at Takeda since September 2019, Ingrid Lux has previously held senior roles at Sandoz / Salutas, focusing on quality operations and lifecycle management of pharmaceutical products. Ingrid Lux's earlier career includes significant contributions to Crucea Albastra România (CARO) as board president, advocating for substance addiction support, and project management at DWEKD overseeing perfusion units. Educationally, Ingrid Lux holds an MBA in Organizational Management and has a medical degree from the University of Medicine and Pharmacy "Iuliu Hațieganu."